New pill for eye disease tested in healthy volunteers first
Knowledge-focused
Recruiting now
This early-stage study tests the safety of an experimental oral drug called DC6001 in 76 healthy adults aged 18-55. The drug is being developed for Stargardt disease, a genetic eye condition, but this trial does not involve people with the disease. Participants receive either the…
Phase: PHASE1 • Sponsor: Heronova Pharmaceuticals • Aim: Knowledge-focused
Last updated May 06, 2026 16:02 UTC